Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

This study has been completed.
Sponsor:
Collaborator:
Immunex Corporation
Information provided by:
Abgenix
ClinicalTrials.gov Identifier:
NCT00061126
First received: May 21, 2003
Last updated: June 23, 2005
Last verified: September 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given